Glaucoma: now and beyond

H Jayaram, M Kolko, DS Friedman, G Gazzard - The Lancet, 2023 - thelancet.com
The glaucomas are a group of conditions leading to irreversible sight loss and characterised
by progressive loss of retinal ganglion cells. Although not always elevated, intraocular …

Ophthalmological manifestations of Axenfeld-Rieger syndrome: Current perspectives

K Michels, BL Bohnsack - Clinical Ophthalmology, 2023 - Taylor & Francis
Axenfeld-Rieger syndrome (ARS) is a rare congenital disease that is primarily characterized
by ocular anterior segment anomalies but is also associated with craniofacial, dental …

Primary open-angle glaucoma preferred practice pattern®

SJ Gedde, K Vinod, MM Wright, KW Muir, JT Lind… - Ophthalmology, 2021 - Elsevier
Background Primary open angle glaucoma (POAG) is a chronic, progressive ocular disease
causing loss of the optic nerve rim and retinal nerve fiber layer (RNFL) with associated …

[PDF][PDF] Primary open-angle glaucoma preferred practice pattern® guidelines

BE Prum, LF Rosenberg, SJ Gedde, SL Mansberger… - …, 2016 - academia.edu
Primary open-angle glaucoma (POAG) is a chronic, progressive optic neuropathy in adults
in which there is a characteristic acquired atrophy of the optic nerve and loss of retinal …

[HTML][HTML] Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year …

TW Samuelson, SR Sarkisian Jr, DM Lubeck, MC Stiles… - Ophthalmology, 2019 - Elsevier
Purpose Evaluate the safety and effectiveness of an ab interno implanted (iStent inject)
Trabecular Micro-Bypass System (Glaukos Corporation, San Clemente, CA) in combination …

Safety and effectiveness of CyPass supraciliary micro-stent in primary open-angle glaucoma: 5-year results from the COMPASS XT study

G Reiss, B Clifford, S Vold, J He, C Hamilton… - American Journal of …, 2019 - Elsevier
Purpose To characterize the long-term (up to 5 years) safety and effectiveness of the
supraciliary Micro-Stent (Alcon) implanted at the time of phacoemulsification in eyes with …

Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month …

LJ Katz, C Erb, A Carceller Guillamet, AM Fea… - Clinical …, 2018 - Taylor & Francis
Purpose Evaluate long-term outcomes after one, two, or three trabecular micro-bypass
stents implanted in a standalone procedure in eyes with open-angle glaucoma taking ocular …

Prospective Evaluation of Two iStent® Trabecular Stents, One iStent Supra® Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year …

JS Myers, I Masood, DM Hornbeak, JI Belda… - Advances in …, 2018 - Springer
Introduction This study evaluates long-term outcomes of two trabecular micro-bypass stents,
one suprachoroidal stent, and postoperative prostaglandin in eyes with refractory open …

Trabeculectomy bleb-associated infections

MR Razeghinejad, SJ Havens, LJ Katz - survey of ophthalmology, 2017 - Elsevier
Trabeculectomy with antimetabolites is the most commonly performed surgery worldwide for
glaucoma patients with progressive optic nerve head injury and visual field loss despite …

Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT

AJ King, G Fernie, J Hudson… - Health …, 2021 - research-repository.st-andrews.ac …
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high
risk of lifetime blindness. Uncertainty exists about whether primary medical management …